UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Blood, 2014-10, Vol.124 (16), p.2507-2513

2014

Volltextzugriff (PDF)

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

The New England journal of medicine, 2015-09, Vol.373 (10), p.908-919

2015

Volltextzugriff (PDF)

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

American journal of hematology, 2014-08, Vol.89 (8), p.E121-E124

2014

Volltextzugriff (PDF)

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study

American journal of hematology, 2014-12, Vol.89 (12), p.1111-1115

2014

Volltextzugriff (PDF)

Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer

Medical oncology (Northwood, London, England), 2017-10, Vol.34 (10), p.170-170, Article 170

2017

Volltextzugriff (PDF)

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Blood, 2014-10, Vol.124 (15), p.2465-2466

2014

Volltextzugriff (PDF)

Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome

American journal of hematology, 2015-05, Vol.90 (5), p.411-416

2015

Volltextzugriff (PDF)

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

British journal of haematology, 2016-11, Vol.175 (3), p.534-536

2016

Volltextzugriff (PDF)

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients

British journal of haematology, 2015-04, Vol.169 (1), p.71-76

2015

Volltextzugriff (PDF)

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

European journal of haematology, 2015-01, Vol.94 (1), p.31-36

2015

Volltextzugriff (PDF)

Next‐generation sequencing in systemic mastocytosis: Derivation of a mutation‐augmented clinical prognostic model for survival

American journal of hematology, 2016-09, Vol.91 (9), p.888-893

2016

Volltextzugriff (PDF)

PET avidity and tumor clinical and pathological features in breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12623-e12623

2018

Volltextzugriff (PDF)

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Blood, 2014-12, Vol.124 (21), p.1932-1932

2014

Volltextzugriff (PDF)

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

Blood, 2014-12, Vol.124 (21), p.403-403

2014

Volltextzugriff (PDF)

CD123 Immunostaining in Systemic Mastocytosis: Differential Expression in Disease Subgroups and Potential Prognostic Value

Blood, 2015-12, Vol.126 (23), p.2802-2802

2015

Volltextzugriff (PDF)

ASXL1 and CBL Mutations Are Independently Predictive of Inferior Survival in Advanced Systemic Mastocytosis

Blood, 2015-12, Vol.126 (23), p.828-828

2015

Volltextzugriff (PDF)

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Blood, 2014-12, Vol.124 (21), p.631-631

2014

Volltextzugriff (PDF)

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Blood, 2014-12, Vol.124 (21), p.3166-3166

2014

Volltextzugriff (PDF)

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Blood, 2014-12, Vol.124 (21), p.412-412

2014

Volltextzugriff (PDF)

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

Blood, 2013-11, Vol.122 (21), p.1587-1587

2013

Volltextzugriff (PDF)

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Blood, 2013-11, Vol.122 (21), p.4060-4060

2013

Volltextzugriff (PDF)

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

Blood, 2014-12, Vol.124 (21), p.4633-4633

2014

Volltextzugriff (PDF)

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a M ayo C linic‐ F rench C onsortium S tudy

American journal of hematology, 2014-12, Vol.89 (12), p.1111-1115

2014

Volltextzugriff (PDF)

Cytomorphological patterns and clinical features of presumptive tubercular lymphadenitis patients and their comparison with bacteriological detection methods: a cross-sectional study

BMC infectious diseases, 2024-07, Vol.24 (1), p.684-9, Article 684

2024

Volltextzugriff (PDF)

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

BMC infectious diseases, 2022-03, Vol.22 (1), p.261-261, Article 261

2022

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic‐French Consortium Study

Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

Next‐generation sequencing in systemic mastocytosis: Derivation of a mutation‐augmented clinical prognostic model for survival

PET avidity and tumor clinical and pathological features in breast cancer

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

CD123 Immunostaining in Systemic Mastocytosis: Differential Expression in Disease Subgroups and Potential Prognostic Value

ASXL1 and CBL Mutations Are Independently Predictive of Inferior Survival in Advanced Systemic Mastocytosis

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a M ayo C linic‐ F rench C onsortium S tudy

Cytomorphological patterns and clinical features of presumptive tubercular lymphadenitis patients and their comparison with bacteriological detection methods: a cross-sectional study

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

Suchergebnisse filtern